"GABA Agents" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Substances used for their pharmacological actions on GABAergic systems. GABAergic agents include agonists, antagonists, degradation or uptake inhibitors, depleters, precursors, and modulators of receptor function.
| Descriptor ID |
D018682
|
| MeSH Number(s) |
D27.505.519.625.240 D27.505.696.577.240
|
| Concept/Terms |
GABA Agents- GABA Agents
- Agents, GABA
- gamma-Aminobutyric Acid Agents
- Acid Agents, gamma-Aminobutyric
- Agents, gamma-Aminobutyric Acid
- gamma Aminobutyric Acid Agents
- GABAergic Agent
- Agent, GABAergic
- GABAergic Agents
- Agents, GABAergic
GABA Effect- GABA Effect
- Effect, GABA
- GABAergic Effect
- Effect, GABAergic
- GABAergic Effects
- Effects, GABAergic
- GABA Effects
- Effects, GABA
|
Below are MeSH descriptors whose meaning is more general than "GABA Agents".
Below are MeSH descriptors whose meaning is more specific than "GABA Agents".
This graph shows the total number of publications written about "GABA Agents" by people in this website by year, and whether "GABA Agents" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1998 | 1 | 0 | 1 |
| 2001 | 0 | 1 | 1 |
| 2002 | 1 | 0 | 1 |
| 2003 | 1 | 0 | 1 |
| 2005 | 1 | 0 | 1 |
| 2006 | 1 | 1 | 2 |
| 2010 | 0 | 1 | 1 |
| 2011 | 0 | 1 | 1 |
| 2015 | 0 | 1 | 1 |
| 2016 | 0 | 1 | 1 |
| 2017 | 1 | 0 | 1 |
| 2018 | 0 | 1 | 1 |
| 2019 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "GABA Agents" by people in Profiles.
-
New agents and perspectives in the pharmacological treatment of major depressive disorder. Prog Neuropsychopharmacol Biol Psychiatry. 2021 03 02; 106:110157.
-
Treating Alcohol Use Disorder in U.S. Veterans: The Role of Traumatic Brain Injury. J Neuropsychiatry Clin Neurosci. 2019; 31(4):319-327.
-
Vigabatrin: Lessons Learned From the United States Experience. J Neuroophthalmol. 2018 12; 38(4):442-450.
-
Valproic Acid Attenuates Postoperative Psychosis Following Aggressive Resection of an Intracardiac Carcinoid Neuroendocrine Tumor: A Case Report. Psychosomatics. 2018 11; 59(6):607-611.
-
The Association between GABA-Modulators and Clostridium difficile Infection - A Matched Retrospective Case-Control Study. PLoS One. 2017; 12(1):e0169386.
-
Catatonia secondary to synthetic cannabinoid use in two patients with no previous psychosis. Am J Addict. 2016 Jan; 25(1):25-7.
-
Apolipoprotein A-IV Inhibits AgRP/NPY Neurons and Activates Pro-Opiomelanocortin Neurons in the Arcuate Nucleus. Neuroendocrinology. 2016; 103(5):476-488.
-
New directions in reducing stress effects on cancer. Cancer Prev Res (Phila). 2012 Feb; 5(2):147-9.
-
Novel pharmacotherapeutic treatments for cocaine addiction. BMC Med. 2011 Nov 03; 9:119.
-
Divalproex sodium-ER in outpatients with disruptive behavior disorders: a three month open label study. Child Psychiatry Hum Dev. 2010 Jun; 41(3):274-84.